Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.70%45.36B | 7.83%42.91B | 8.61%11.84B | 0.90%10.58B | 18.87%12.96B | 0.35%7.54B | 14.45%39.8B | 13.18%10.9B | 12.81%10.48B | 17.09%10.9B |
| Cost of revenue | 5.61%35.45B | 7.47%33.57B | 7.18%9.12B | 2.29%8.28B | 16.95%9.99B | 1.48%6.17B | 13.73%31.23B | 11.93%8.51B | 9.58%8.1B | 18.34%8.54B |
| Gross profit | 6.04%9.91B | 9.13%9.35B | 13.67%2.72B | -3.73%2.3B | 25.80%2.97B | -4.48%1.37B | 17.17%8.57B | 17.95%2.39B | 25.18%2.39B | 12.78%2.36B |
| Operating expense | 2.88%5.79B | 8.62%5.63B | 9.96%1.54B | 7.75%1.34B | 10.41%1.37B | 6.34%1.39B | 6.23%5.18B | 11.32%1.4B | 0.65%1.24B | 2.40%1.24B |
| Staff costs | 1.49%3.89B | 5.30%3.83B | ---- | ---- | ---- | ---- | 5.20%3.64B | ---- | ---- | ---- |
| Selling and administrative expenses | -3.45%168M | 27.94%174M | ---- | ---- | ---- | ---- | 33.33%136M | ---- | ---- | ---- |
| -General and administrative expense | -3.45%168M | 27.94%174M | ---- | ---- | ---- | ---- | 33.33%136M | ---- | ---- | ---- |
| Research and development costs | -2.03%290M | 11.70%296M | ---- | ---- | ---- | ---- | 26.79%265M | ---- | ---- | ---- |
| Depreciation and amortization | 56.52%108M | 43.75%69M | ---- | ---- | ---- | ---- | 54.84%48M | ---- | ---- | ---- |
| -Depreciation | 56.52%108M | 43.75%69M | ---- | ---- | ---- | ---- | 54.84%48M | ---- | ---- | ---- |
| Rent and land expenses | 1.32%231M | -2.56%228M | ---- | ---- | ---- | ---- | -1.27%234M | ---- | ---- | ---- |
| Other operating expenses | 7.28%1.11B | 19.77%1.03B | ---- | ---- | ---- | ---- | 2.38%860M | ---- | ---- | ---- |
| Operating profit | 10.84%4.12B | 9.91%3.72B | 18.88%1.18B | -16.13%962M | 42.84%1.6B | -122.50%-27M | 39.14%3.38B | 28.68%996M | 69.93%1.15B | 27.05%1.12B |
| Net non-operating interest income (expenses) | 0 | 0 | 0 | 0 | 0 | 0 | -2M | 0 | -1M | -1M |
| Non-operating interest income | --1M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Non-operating interest expense | --1M | --0 | --0 | --0 | --0 | --0 | --2M | --0 | --1M | --1M |
| Net investment income | 25M | -4M | 0 | 2M | -4M | |||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 17.86%-23M | 133.33%9M | 75.00%-2M | -528.57%-30M | 0 | -1,033.33%-28M | -2,800.00%-27M | -8M | 7M |
| Less:Other special charges | ---- | -136.84%-7M | -150.00%-9M | ---- | ---- | ---- | 733.33%19M | 1,900.00%18M | --8M | ---- |
| Less:Write off | --0 | 233.33%30M | --0 | --0 | ---- | ---- | --9M | --9M | --0 | ---- |
| Other non-operating income (expenses) | 133.33%1M | -50.00%-3M | -1M | -1M | 0.00%-2M | 0 | ||||
| Income before tax | 12.29%4.14B | 10.56%3.69B | 23.98%1.19B | -15.73%959M | 39.64%1.56B | -122.22%-26M | 37.60%3.33B | 24.71%959M | 69.09%1.14B | 27.27%1.12B |
| Income tax | 9.62%1.2B | 13.51%1.09B | 39.57%321M | -15.23%295M | 29.82%431M | -13.46%45M | 24.29%962M | -2.54%230M | 51.30%348M | 22.96%332M |
| Net income | 13.42%2.94B | 9.32%2.59B | 18.77%867M | -15.82%665M | 43.84%1.13B | -209.23%-71M | 43.93%2.37B | 37.22%730M | 77.93%790M | 29.23%787M |
| Net income continuous operations | 13.42%2.94B | 9.36%2.59B | 19.07%868M | -15.95%664M | 43.78%1.13B | -209.23%-71M | 43.84%2.37B | 36.77%729M | 78.33%790M | 29.18%788M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 13.42%2.94B | 9.32%2.59B | 18.77%867M | -15.82%665M | 43.84%1.13B | -209.23%-71M | 43.93%2.37B | 37.22%730M | 77.93%790M | 29.23%787M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 13.42%2.94B | 9.32%2.59B | 18.77%867M | -15.82%665M | 43.84%1.13B | -209.23%-71M | 43.93%2.37B | 37.22%730M | 77.93%790M | 29.23%787M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 13.42%152.568 | 9.32%134.52 | 18.80%44.97 | -15.88%34.47 | 43.97%58.812 | -210.68%-3.732 | 43.90%123.054 | 37.09%37.854 | 78.04%40.978 | 29.30%40.85 |
| Diluted earnings per share | 13.42%152.568 | 9.32%134.52 | 18.80%44.97 | -15.88%34.47 | 43.84%58.7181 | -210.68%-3.732 | 43.90%123.054 | 37.18%37.854 | 78.04%40.9766 | 29.23%40.821 |
| Dividend per share | 90.00%76 | 8.11%40 | 8.11%40 | 0 | 0 | 0 | 42.31%37 | 42.31%37 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |